147 related articles for article (PubMed ID: 17998090)
21. Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
Cornelissen B; Hu M; McLarty K; Costantini D; Reilly RM
Nucl Med Biol; 2007 Jan; 34(1):37-46. PubMed ID: 17210460
[TBL] [Abstract][Full Text] [Related]
22.
Cai Z; Chattopadhyay N; Yang K; Kwon YL; Yook S; Pignol JP; Reilly RM
Nucl Med Biol; 2016 Dec; 43(12):818-826. PubMed ID: 27788375
[TBL] [Abstract][Full Text] [Related]
23. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C
J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
[TBL] [Abstract][Full Text] [Related]
24. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
McLarty K; Cornelissen B; Cai Z; Scollard DA; Costantini DL; Done SJ; Reilly RM
J Nucl Med; 2009 Aug; 50(8):1340-8. PubMed ID: 19617342
[TBL] [Abstract][Full Text] [Related]
25. A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.
Reilly RM; Scollard DA; Wang J; Mondal H; Chen P; Henderson LA; Bowen BM; Vallis KA
J Nucl Med; 2004 Apr; 45(4):701-8. PubMed ID: 15073268
[TBL] [Abstract][Full Text] [Related]
26. Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software.
Cai Z; Vallis KA; Reilly RM
Int J Radiat Biol; 2009 Mar; 85(3):262-71. PubMed ID: 19296344
[TBL] [Abstract][Full Text] [Related]
27. (111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.
Costantini DL; Chan C; Cai Z; Vallis KA; Reilly RM
J Nucl Med; 2007 Aug; 48(8):1357-68. PubMed ID: 17631548
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
Cornelissen B; Kersemans V; Burvenich I; Oltenfreiter R; Vanderheyden JL; Boerman O; Vandewiele C; Slegers G
Nucl Med Commun; 2005 Feb; 26(2):147-53. PubMed ID: 15657509
[TBL] [Abstract][Full Text] [Related]
29. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.
Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J
J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690
[TBL] [Abstract][Full Text] [Related]
30. Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with
Yook S; Cai Z; Jeong JJ; Lu Y; Winnik MA; Pignol JP; Reilly RM
Mol Pharm; 2020 Apr; 17(4):1226-1236. PubMed ID: 32022567
[TBL] [Abstract][Full Text] [Related]
31. Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
Velikyan I; Sundberg AL; Lindhe O; Höglund AU; Eriksson O; Werner E; Carlsson J; Bergström M; Långström B; Tolmachev V
J Nucl Med; 2005 Nov; 46(11):1881-8. PubMed ID: 16269603
[TBL] [Abstract][Full Text] [Related]
32. The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin).
Cornelissen B; McLarty K; Kersemans V; Reilly RM
Nucl Med Biol; 2008 Aug; 35(6):645-53. PubMed ID: 18678349
[TBL] [Abstract][Full Text] [Related]
33. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
34. [177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.
Sundberg AL; Gedda L; Orlova A; Bruskin A; Blomquist E; Carlsson J; Tolmachev V
Cancer Biother Radiopharm; 2004 Apr; 19(2):195-204. PubMed ID: 15186600
[TBL] [Abstract][Full Text] [Related]
35. In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells.
Nordberg E; Orlova A; Friedman M; Tolmachev V; Ståhl S; Nilsson FY; Glimelius B; Carlsson J
Oncol Rep; 2008 Apr; 19(4):853-7. PubMed ID: 18357367
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing the sensitivity of tumor imaging with a receptor-binding radiopharmaceutical.
Reilly RM; Gariépy J
J Nucl Med; 1998 Jun; 39(6):1036-43. PubMed ID: 9627341
[TBL] [Abstract][Full Text] [Related]
37.
Kwon LY; Scollard DA; Reilly RM
Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
[TBL] [Abstract][Full Text] [Related]
38. Panitumumab-DOTA-
Facca VJ; Cai Z; Gopal NEK; Reilly RM
Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
[TBL] [Abstract][Full Text] [Related]
39. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Müller C; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
[TBL] [Abstract][Full Text] [Related]
40. Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
McLarty K; Cornelissen B; Scollard DA; Done SJ; Chun K; Reilly RM
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):81-93. PubMed ID: 18712381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]